Dr. Reddy's Laboratories stock heads toward October 23 results
Published on 10/04/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dr. Reddy's Laboratories stock (ISIN US2561352038) was last at USD 12.25 on the NYSE on October 2, 2026, with a 52-week range of USD 11.36 to USD 15.67. The next results checkpoint is scheduled for October 23, 2026.
October 23 brings the next results
According to StockTitan, Dr. Reddy's Laboratories said on September 22, 2026, that its board will consider unaudited standalone and consolidated results for the quarter ended September 30, 2026, on October 23, 2026. The related trading-window closure runs from September 24, 2026, through October 25, 2026.
That date puts the focus on whether the company can repair the earnings damage reported for Q1 FY27. ScanX reported that quarterly revenue fell 5.6 percent year over year to INR 8,071 crore, while net profit was INR 443 crore and EBITDA margin stood at 12.5 percent.
Q1 pressure sets a demanding comparison
The Q1 figures show why the October report matters. The semaglutide API disruption led to an INR 240 crore provision, while the reported EBITDA margin of 12.5 percent reflected the operational hit. ScanX also reported that India revenue rose 70 percent year over year to INR 1,788 crore, creating a sharp contrast with the weaker consolidated result.
Market expectations remain measured. Investing.com lists five analysts at a Neutral consensus, with two Buy, two Hold and one Sell rating. The average 12-month price target is USD 13.29, with a high estimate of USD 15.29952774 and a low estimate of USD 11.28792294. The average target lies 8.49 percent above the USD 12.25 reference price.
RDY remains 21.8 percent below its high
RDY had a market capitalization of USD 10.2 billion and volume of 3,630,160 shares on October 2, 2026. Its USD 12.25 reference price stood 21.8 percent below the 52-week high of USD 15.67, leaving the October results as the next quantified test for margins and growth.
Dr. Reddy's Laboratories stock facts
- Company: Dr. Reddy's Laboratories Limited
- ISIN: US2561352038
- Ticker: RDY
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 12.25
- Market capitalization: USD 10.2 billion (as of October 2, 2026)
- 52-week range: USD 11.36-15.67 (as of October 2, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
Upcoming dates for Dr. Reddy's Laboratories stock
- October 23, 2026: Board meeting to consider Q2 FY27 results
